One survivor explains how joining a clinical trial for an experimental drug saved his life after he was informed that he only had four weeks to live. Keith Taggart shares his story in this episode of the “CURE® Talks Cancer” podcast.

CURE Talks Cancer

103: The Importance of Genomic Testing: How One Survivor Became Cancer-Free After Being Given Four Weeks to Live

A weekly podcast on what CURE magazine (https://www.curetoday.com) does best: provide Cancer Updates Research and Education. Each week, you'll hear from patients, survivors, caregivers, advocates or health care professionals regarding the entire cancer continuum - ranging from specific cancer types to side effects to the psychological strains a cancer diagnosis can have on an individual and their loved ones. As the largest consumer magazine in the United States for patient, survivors and caregivers, we strive to combine science with humanity to make cancer understandable. To learn more, you can also visit us on Facebook (https://www.facebook.com/curemagazine), Twitter (https://twitter.com/cure_magazine) and Instagram (https://instagram.com/curetoday)!

About

CURE Talks Cancer